ClinConnect ClinConnect Logo
Search / Trial NCT04564794

Prognostic Value of Cardial Stress Perfusion Imaging

Launched by CENTRAL HOSPITAL, NANCY, FRANCE · Sep 21, 2020

Trial Information

Current as of June 13, 2025

Completed

Keywords

Coronary Myocardial Perfusion Tomoscintigraphy.

ClinConnect Summary

Stress myocardial perfusion scintigraphy is a reference examination for the detection and monitoring of coronary patients, and this examination has already been the subject of multiple validation studies, including for the stratification of the prognosis of these patients, information that can usefully guide therapeutic choices (medical treatment, myocardial revascularization, ...). The arrival of new solid-state cameras has been a real technological leap for this examination, making it possible to significantly improve the quality of the images and also to drastically reduce the activities...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Any coronary patient suspected or proven to have had a stress myocardial perfusion tomoscintigraphy performed at the Nancy CHRU and corresponding to a standardized model of expression of results (i.e. more than 10,000 reports).
  • Exclusion Criteria:
  • None

About Central Hospital, Nancy, France

Central Hospital, located in Nancy, France, is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes. As a prominent clinical trial sponsor, the hospital is committed to conducting innovative studies across various therapeutic areas, fostering collaboration among multidisciplinary teams of healthcare professionals and researchers. With a strong emphasis on ethical standards and patient safety, Central Hospital leverages its state-of-the-art facilities and expertise to contribute to the development of cutting-edge treatments and enhance the overall quality of care within the community and beyond.

Locations

Vandœuvre Lès Nancy, Grand Est, France

Patients applied

0 patients applied

Trial Officials

Pierre-Yves Marie, MD, PhD

Study Director

Nancy CHRU hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials